Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Laquinimod - New Promising Treatment for Multiple Sclerosis
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Translating Fatigue to Human Performance.
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf.
[Multiple sclerosis : actuality and therapeutic prospects].
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Rituximab: Don't Count It Out as MS Treatment
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Laquinimod for multiple sclerosis.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.

Pages